A University of Manchester led trial of a new psoriasis drug has resulted in 40 percent of people showing a complete clearance of psoriatic plaques after 12 weeks of treatment and over 90 percent...
Simon Fraser University PhD graduate Maryam Sadeghi will unveil MoleScope™, an innovative hand-held tool that uses a smartphone to monitor skin for signs of cancer, at the World Congress of...
LEO Pharma A/S has announced that new data being presented at the 23rd World Congress of Dermatology shows aerosol foam Enstilar® (calcipotriol/betamethasone dipropionate 50 micrograms/g / 0,5...
MSD (known as Merck & Co., Inc. in the US and Canada) has announced the availability in the UK of Sivextro® (tedizolid phosphate) for the treatment of acute bacterial skin and skin structure...
Investigators from Montefiore Einstein Center for Cancer Care have announced new findings from an extensive literature review published in the Annals of Oncology.
Novartis has announced data from the Phase III COMBI-d study showing a significant survival benefit for patients with BRAF V600E/K mutation-positive metastatic melanoma when treated with the...
Researchers reproduced type 2 diabetes in rabbits by continually exposing them to a superantigen released by a type of bacteria that typically increases in people who gain weight.
The incidence of melanoma, a deadly form of skin cancer, has increased by more than 250% among children, adolescents and young adults since 1973, according to award-winning research to be presented...